XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Redemption of units for stock
Series D Units
Redemption of units for cash
Redemption of units for cash
Series B Units
Preferred Operating Partnership
Preferred Operating Partnership
Redemption of units for stock
Series D Units
Preferred Operating Partnership
Redemption of units for cash
Series B Units
Operating Partnership
Operating Partnership
Redemption of units for stock
Operating Partnership
Redemption of units for cash
Other
Common Stock
Common Stock
Redemption of units for stock
Common Stock
Redemption of units for stock
Series D Units
Additional Paid-in Capital
Additional Paid-in Capital
Redemption of units for stock
Additional Paid-in Capital
Redemption of units for stock
Series D Units
Additional Paid-in Capital
Redemption of units for cash
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2017 $ 2,723,807       $ 159,636     $ 213,301     $ 119 $ 1,260     $ 2,569,485       $ 33,290 $ (253,284)
Beginning balance (in shares) at Dec. 31, 2017                       126,007,091                
Increase (Decrease) in Stockholders' Equity                                        
Issuance of common stock upon the exercise of options $ 1,169                           1,169          
Issuance of common stock upon the exercise of options (in shares) 54,575                     54,575                
Restricted stock grants issued $ 1                     $ 1                
Restricted stock grants issued (in shares)                       85,066                
Restricted stock grants cancelled (in shares)                       (11,771)                
Issuance of common stock, net of offering costs 90,231                     $ 10     90,221          
Issuance of common stock, net of offering costs (in shares)                       933,789                
Compensation expense related to stock-based awards 11,176                           11,176          
Repayment of receivable for preferred operating units pledged as collateral on loan 495       495                              
Issuance of Operating Partnership units in conjunction with acquisitions 1,877             1,877                        
Redemption of noncontrolling interests 0   $ (2,558)           $ (1,337) $ (1,126)           $ 1,337   $ (1,432)    
Redemption of noncontrolling interests (in shares)                         35,000              
Conversion of Preferred C Units in the Operating Partnership for Common Operating Partnership Units 0       (6,851)     6,851                        
Noncontrolling interest in consolidated joint venture 122                   122                  
Repurchase of equity portion of 2013 exchangeable senior notes (31,251)                           (31,251)          
Net income (loss) 447,080       13,995     17,797     (1)                 415,289
Other comprehensive income (loss) 1,430       12     58                     1,360  
Distributions to Operating Partnership units held by noncontrolling interests (33,250)       (14,191)     (19,059)                        
Dividends paid on common stock (424,907)                                     (424,907)
Ending balance at Dec. 31, 2018 2,785,422       153,096     218,362     240 $ 1,271     2,640,705       34,650 (262,902)
Ending balance (in shares) at Dec. 31, 2018                       127,103,750                
Increase (Decrease) in Stockholders' Equity                                        
Issuance of common stock upon the exercise of options $ 3,063                     $ 3     3,060          
Issuance of common stock upon the exercise of options (in shares) 211,057                     211,057                
Restricted stock grants issued $ 2                     $ 2                
Restricted stock grants issued (in shares)                       109,081                
Restricted stock grants cancelled (in shares)                       (8,863)                
Issuance of common stock, net of offering costs 198,827                     $ 19     198,808          
Issuance of common stock, net of offering costs (in shares)                       1,779,200                
Compensation expense related to stock-based awards 13,051                           13,051          
Repayment of receivable for preferred operating units pledged as collateral on loan 1,211             1,211                        
Issuance of Operating Partnership units in conjunction with acquisitions 28,022       28,022                              
Redemption of noncontrolling interests 0               (13,057)             13,057        
Redemption of noncontrolling interests (in shares)                         340,182              
Conversion of Preferred C Units in the Operating Partnership for Common Operating Partnership Units 0       (4,374)     4,374                        
Noncontrolling interest in consolidated joint venture 173                   173                  
Net income (loss) 451,123       12,492     18,711     (47)                 419,967
Other comprehensive income (loss) (66,843)       (407)     (2,820)                     (63,616)  
Distributions to Operating Partnership units held by noncontrolling interests (34,243)       (12,881)     (21,362)                        
Dividends paid on common stock (458,114)                                     (458,114)
Ending balance at Dec. 31, 2019 $ 2,921,694       175,948     205,419     366 $ 1,295     2,868,681       (28,966) (301,049)
Ending balance (in shares) at Dec. 31, 2019 129,534,407                     129,534,407                
Increase (Decrease) in Stockholders' Equity                                        
Issuance of common stock upon the exercise of options $ 4,759                     $ 1     4,758          
Issuance of common stock upon the exercise of options (in shares) 134,930                     134,930                
Issuance of common stock in connection with share based compensation (in shares)                       143,187                
Issuance of common stock in connection with share based compensation $ 16,281                     $ 1     16,280          
Restricted stock grants cancelled (in shares)                       (5,083)                
Issuance of common stock, net of offering costs 103,468                     $ 9     103,459          
Issuance of common stock, net of offering costs (in shares)                       899,048                
Buyback of common stock, net of offering costs (67,873)                     $ (8)               (67,865)
Buyback of common stock, net of offering costs (in shares)                       (826,797)                
Repayment of receivable for preferred operating units pledged as collateral on loan 16,213             16,213                        
Redemption of noncontrolling interests 0 $ 0   $ (1,000)   $ (2,724) $ (1,000)   $ (4,572)       $ 1 $ 1   4,571 $ 2,723      
Redemption of noncontrolling interests (in shares)       40,000                 123,993 30,495            
Repurchase of equity portion of 2015 exchangeable senior notes 0                       $ 14     $ (14)        
Repurchase of equity portion of 2015 exchangeable senior notes (in shares)                         1,323,781              
Noncontrolling interest in consolidated joint venture 66                   66                  
Net income (loss) 517,582       12,882     22,952     (31)                 481,779
Other comprehensive income (loss) (73,686)       (456)     (3,103)                     (70,127)  
Distributions to Operating Partnership units held by noncontrolling interests (33,615)       (12,598)     (21,017)                        
Dividends paid on common stock (467,765)                                     (467,765)
Ending balance at Dec. 31, 2020 $ 2,936,124       $ 172,052     $ 215,892     $ 401 $ 1,314     $ 3,000,458       $ (99,093) $ (354,900)
Ending balance (in shares) at Dec. 31, 2020 131,357,961                     131,357,961